1. Introduction {#s0005}
===============

Various neuropsychological measures have been developed for cognitive screening in patients with psychotic disorders ([@bb0240]; [@bb0150]). This is because cognitive impairment is a key predictor of outcomes like quality of life in patients with psychotic disorders. Cognitive impairment contributes a larger portion of disease burden than behavioral, positive or negative symptoms of psychosis ([@bb0100]; [@bb0065]; [@bb0315]). Cognitive screening is therefore an essential component of routine care for patients with psychotic disorders ([@bb0010]; [@bb0320]). Cognitive screening in psychotic disorders involves administering neuropsychological measures to assess for cognitive impairment. Although various cognitive domains can be impaired, research by the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative recommended seven key domains for neuropsychological assessment in patients with psychotic disorders. These are i) working memory, ii) attention/vigilance, iii) verbal learning and memory, iv) visual learning and memory, v) reasoning and problem solving, vi) information processing speed, and vii) social cognition ([@bb0095]; [@bb0220]).

The American Psychological Association\'s Working Group on Screening and Assessment (WGSA) have provided guidelines for assessing whether neuropsychological measures are appropriate for cognitive screening in clinical settings ([@bb0015]). WGSA was a collaboration of the American Psychological Association\'s Board of Professional Affairs and the Committee for the Advancement of Professional Practice of the American Psychological Association to help distinguish cognitive screening from comprehensive psychological evaluations ([@bb0265]). Briefly, the guidelines state that for a measure to have clinical utility for cognitive screening it must be: a) able to identify early on individuals at high risk for impairment, b) be sensitive enough to determine those who need further review; c) be brief and narrow in scope; d) be administered as part of a routine clinic visit; e) be administered by clinicians or support staff or with electronic devices and; f) be used to monitor progress and outcomes ([@bb0265]). Several brief neuropsychological measures such as the Brief Assessment of Cognition in Schizophrenia (BACS) have been shown to meet these criteria in high-income countries (HIC) ([@bb0080]; [@bb0140]).

In low- and middle-income countries (countries with a gross national income of less than \$5101 <https://data.worldbank.org/income-level/low-and-middle-income>) there is a growing literature on neuropsychological measures for psychotic disorders ([@bb0025]; [@bb0030]; [@bb0205]; [@bb0210]). Such work has been useful in demonstrating the large burden of impairment and its association with poor outcomes ([@bb0030]). However, it is unclear if measures that have been researched are appropriate for cognitive screening. In particular, it is unclear whether these neuropsychological measures meet the criteria for cognitive screening as outlined by the WGSA. It would be useful to know if the tests are used early in the course of the illness, whether these assessments have been validated against comprehensive neuropsychological batteries, duration and scope of the tests, setting where the tests are performed, the personnel administering the tests and whether the tests are used for follow up of patients.

Here we aimed to determine if the neuropsychological measures used in research on patients with psychotic disorders in low- and middle-income country contexts meet the six WSGA clinical utility criteria for cognitive screening. A systematic review was undertaken following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ([@bb0185]). The study protocol was registered prior to data collection in the open access online registry, PROSPERO, University of York, York, United Kingdom, registration number **CRD42018047872**. <http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018047872>.

2. Methods {#s0010}
==========

2.1. Study selection {#s0015}
--------------------

Exclusion and inclusion criteria were determined using the PICOSS (Population, Intervention, Comparator, Outcomes, Study design, Setting) framework ([@bb0260]). We considered articles written in English with no time limit on when the studies were conducted. The **population** of interest was participants with psychosis. Psychosis was defined as participants with schizophrenia spectrum and related psychotic disorders, bipolar affective disorder and depression with psychotic features. We selected these disorders given the current literature that highlights their shared genetic and neurobiological underpinnings ([@bb0270]; [@bb0165]). The **intervention** included any study in which neuropsychological measures were performed in at least one cognitive domain. This was done to ensure that neuropsychological measures that are used for assessment and not screening, such as the MATRICS consensus cognitive battery, were excluded. The **comparator** was healthy controls. Our **outcomes** included the clinical diagnosis, whether these assessments had been validated against comprehensive batteries, duration and scope of the tests, setting where the tests were performed, the personnel who administered the tests and whether the tests are used for follow up of patients. All **study designs** irrespective of sample size were included in the review. The review was limited to the low and middle-income country **setting**. This was done due to the disparity in care between high income (GNI \> \$5101) and low-income countries (GNI \< \$5101).

2.2. Data sources, search strategy, screening and abstraction {#s0020}
-------------------------------------------------------------

In consultation with a librarian (RS), data sources included (a) electronic search of databases, (b) search for gray literature (conference proceedings, clinical trial registers) and (c) using the reference bibliography of full text articles to identify potentially relevant studies. The electronic search strategy followed the PICOS approach (Population, Intervention, Comparator, Outcome and Study design/setting), and was conducted in three databases including PubMed, Embase and PsychINFO. Only English language articles were included into the review. The complete search strategy is in the supplementary files. The search strategy used Boolean logic to combine terms in the PICOS framework. Articles were saved into Endnote ([@bb0040]), duplicates removed and two authors (EKM & JLO) independently screened the titles and abstracts to determine which articles were eligible for the review in parallel, before retrieving full texts. A consensus meeting was held when there was disagreement. For each study, abstracted data included name of the test, the domains they assessed, duration of assessments, personnel administering the tests, the types of assessments (paper vs computerized), and whether the tests had been validated against a gold standard.

2.3. Quality assessment {#s0025}
-----------------------

Studies with a poor risk of bias assessment were not excluded from the final analysis. However, duplicate publications were removed to limit publication bias. Bias assessment was undertaken by the primary reviewer (EKM) in consultation with DA, JLG and EAO.

2.4. Data synthesis {#s0030}
-------------------

We performed a structured narrative synthesis were words and text are used to summarize and explain the findings of the review ([@bb0230]). Quantitative data was analyzed using Stata version 14. (StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP).

The criterion (a) of a test being able to identify early on individuals at high risk for impairment was assessed by abstracting the clinical diagnosis to determine which tests were performed early at the first episode of psychosis. The criterion (b) of a test needing to be sensitive enough to determine those who need further review was assessed by determining the tests that had been validated against a comprehensive neuropsychological battery. The criterion (c) of a test being brief and narrow in scope was assessed by the number of domains assessed and the duration of the assessment. The criterion (d) of a test administered as part of a routine clinic visit was assessed by determining the setting (inpatient versus outpatient) in which the tests were performed. These settings were chosen since neuropsychological assessments are performed on resolution of psychotic symptoms which is often in outpatient not inpatient settings ([@bb0115]; [@bb0240]). The criterion (e) of a test administered by clinicians or support staff with electronic devices was assessed by determining the mode of delivery of the test (pen and paper versus computerized) and the personnel administering the tests. Finally, the criterion (f) of a test used to monitor progress and outcomes was assessed by determining the studies that employed a longitudinal study design as well as those that assessed quality of life in participants.

3. Results {#s0035}
==========

3.1. Study setting and population {#s0040}
---------------------------------

The last search using PubMed was undertaken on April 10th, 2020, while the last search using PsycINFO & Embase, was undertaken on 18th October 2018. After removal of duplicates, eligible titles and abstracts were screened according to the inclusion criteria until a final list was agreed upon. The process is highlighted in [Fig. 1](#f0005){ref-type="fig"}. Thirty-one studies were included in the final analysis. The articles were published between 1994 and 2018 with many (15/31) published between the years 2000 and 2010. Seven (7) studies were from Central and South American countries, thirteen (13) were from Asian countries and eleven (11) were from African countries. South Africa had the highest number of individual studies making up 7 of the 31 studies. In total, the final table included 3254 participants with psychosis and 1331 controls.Fig. 1Article selection using PRISMA guidelines.Fig. 1

3.2. Early neuropsychological assessment {#s0045}
----------------------------------------

Only 3 studies were performed early among patients with a first episode of psychosis. The different diagnostic characteristics of the participants are shown in [Table 1](#t0005){ref-type="table"}.Table 1Summary of studies included in the review.Table 1YearAuthorCountryStudy designPopulationPopulation groupTotal number of participantsDiagnostic typeNumber1994GurejeNigeriaCSInpatientBlack128Schizophrenia43Mania32HC531997MattsonSouth AfricaCSOutpatientCaucasian40Schizophrenia positive symptoms20Schizophrenia negative symptoms202002ErtugrulTurkeyCase controlOutpatientCaucasian90Schizophrenia60HC302002HarveySouth AfricaCSOutpatientCaucasian29Schizophrenia English speaking5BlackSchizophrenia Afrikaans speaking242005AleptekinTurkeyCSOutpatientCaucasian69Schizophrenia38HC312006LeppanenSouth AfricaCSOutpatientBlack84Schizophrenia44HC402007SalgadoBrazilCSOutpatientCaucasian40Schizophrenia20InpatientHC202007TrivediIndiaCSOutpatientOriental45BPD15Schizophrenia15HC152007AyresBrazilCSOutpatientCaucasian553Schizophrenia98BPD41Depression with psychosis31HC3832008PradhanBrazilCSOutpatientCaucasian103BPD48InpatientSchizophrenia32HC232008LeppanenSouth AfricaCSOutpatientAfrican81Psychosis36Siblings23HC222008SavitzSouth AfricaCSOutpatientCaucasian230HC65BPD I49BPD II192008SchneiderBrazilCSOutpatientCaucasian94BPD66HC282009SavitzSouth AfricaCSOutpatientCaucasian110BPD with psychosis25BPD without psychosis24HC612010AyresBrazilCSOutpatientCaucasian160Schizophrenia56Affective psychosis34HC702010NgomaDemocratic Republic of CongoCSInpatientBlack341HC153Brief psychotic disorder68Schizophreniform50Schizophrenia702010Cabral-CalderinCubaLongitudinalOutpatientCaucasian68Schizophrenia34HC342011MehtaIndiaCSOutpatientOriental18Schizophrenia9HC92011GuoChinaLongitudinalOutpatientOriental698Schizophrenia578Schizophreniform1202012NakasujjaUgandaLongitudinalInpatientBlack483Mania312Psychosis NOS16Schizophrenia100Depression552013SantoshIndiaCSOutpatientOriental100Schizophrenia1002014Heeramun- AubeeluckChinaLongitudinalOutpatientOriental101FEP1012014OkashaEgyptCSOutpatientBlack90BPD60HC302014MazhariIranCSOutpatientPersian100Schizophrenia50HC502015Arau´ joBrazilCSOutpatientCaucasian174Schizophrenia116HC582016HouChinaCSOutpatientOriental80FEP40HC402016TangChinaCSOutpatientOriental148Schizophrenia94HC542017CharernboonThailandCSOutpatientOriental72Schizophrenia36HC362017ZhouChinaLongitudinalInpatientOriental49FES32HC172017HendricksSouth AfricaCSInpatientCaucasian29Alcohol induced psychosis13Alcohol use162018SagarIndiaLongitudinalOutpatientOriental178BPD depressed36BPD manic41BPD euthymic52HC49[^1]

3.3. Validation of tests {#s0050}
------------------------

Only 3 out of 31 studies specifically evaluated a measure against a comprehensive neuropsychological battery. A summary of the publications and associated validation statistics are shown in [Table 2](#t0010){ref-type="table"}.Table 2Studies in which a brief test was compared to a complete battery.Table 2AuthorValidatedComparison group-selection criteriaComparison group-sizeComparison toolSensitivitySpecificityReliabilityConcurrent validityMehta, 2011NRNRNRNR84.2810.71NRMazhari,2014YESHC50Standard battery98.066.00.74NRArau´ jo, 2015YESHC58BACS- FrenchNRNR0.8740.625[^2]

3.4. Scope and brevity of tests {#s0055}
-------------------------------

The choice of the number of domains assessed differed across the publications with 8 out of 31 publications (25.8%) assessing for impairment in only one domain while 5 out of 31(17%) studies assessed for impairment in six domains. The proportions of domains assessed are shown in the bar graph ([Fig. 2](#f0010){ref-type="fig"}) below. Most tests assessed for impairment in the reasoning and problem-solving domain accounting for 24.64% of all tests in the studies. [Fig. 3](#f0015){ref-type="fig"} highlights the proportions of tests that assessed the other domains. In 6 studies, the time taken to perform the assessments was less than hour. Domains assessed and the time taken to perform the tests is highlighted in [Table 3](#t0015){ref-type="table"}.Fig. 2Bar graph showing number of domains assessed in the publications.Fig. 2Fig. 3Bar chart showing the proportion of domains assessed.Fig. 3Table 3Summary of tests used, domains they assess, duration and who performed test.Table 3AuthorSubtest/scale/batteryDomains assessedAdministration time (hours)Mode of deliveryPerson administering testTraining receivedGureje, 1994. Verbal memory\
. Verbal Fluency\
. Design fluency\
. Wechsler Adult Intelligence Scale (WAIS) (Performance subtests)\
. Wechsler Adult Intelligence Scale (WAIS) (Verbal subtests)VLM, RP, WM, AVNRPen and paperNeuropsychologistNRMattson, 1997. Rey Auditory Verbal Learning Test (RAVLT)\
. Wisconsin Card Sorting Test (Modified)\
. Austin Maze\
. Rey Complex Figure (RCF)\
. Controlled Oral Word Association Test (COWAT)\
. Trail making test\
. Stroop Color and Word TestVLM, RP, IP, AVNRPen and paperClinical psychologistNRErtugrul. 2002. Wechsler Memory Scale Revised\
. Wisconsin card sorting testAV, WM, RP, VSM2Pen and paperNRNRHarvey, 2002. Wechsler Memory scale (revised)\
. Rey Auditory Verbal Learning Test (RAVLT)\
. Continuous performance test (IP version)\
. Verbal fluency\
. Wechsler Adult Intelligence Scale (WAIS)\
. Wisconsin Card Sorting TestWM, VLM, AV, IP, RPNRPen and paperResearch assistantsYESAleptekin, 2005. Wechsler Adult Intelligence Scale (WAIS)\
. Controlled Oral Word Association Test (COWAT)AV, WM, RPNRPen and paperNRNRLeppanen, 2006. Facial affect recognitionSocial cognitionNRComputerNRNRSalgado, 2007. 15 item word list\
. Digit sequencing task\
. Token motor task\
. Category fluency\
. Symbol coding\
. Tower of LondonVLM, WM, AV. RP, IP0.72Pen and paperPsychiatristSingleTrivedi, 2007. Wisconsin Card Sorting Test\
. Continuous performance testRP, AVNRComputerNRNRAyres, 2007. Controlled Oral Word Association Test (COWAT)\
. Wechsler Adult Intelligence Scale (WAIS)VSM, AV, WMNRPen and paperNRPradhan, 2008. Wisconsin Card Sorting Test\
. Trail B\
. Controlled Words Association Test\
. PGI Memory scale\
. Bender Visual Motor Gestalt Test\
. Trail ARP, VLM, WM, IP, AV3.5Pen and paperNRNRLeppanen, 2008. Facial affect recognitionSocial cognitionNRComputerNRNRSavitz, 2008. Wechsler Adult Intelligence Scale (WAIS)\
. Controlled Oral Word Association Test (COWAT)\
. Rey Complex Figure (RCF)\
. Stroop Color and Word test\
. Rey Auditory Verbal Learning Test (RAVLT)\
. Wisconsin Card Sorting Test (64 item)AV, WM, VLM, VLM, IP, RP1Pen and paperNeuropsychologist\
Psychiatric nurse\
Graduate studentsYesSchneider, 2008. Wechsler Adult Intelligence Scale (WAIS) IIIVSM, WM, IPNRNRNRNRSavitz, 2009. Digits span\
. Controlled Oral Word Association Test (COWAT)\
. Rey Complex Figure (RCF)\
. Stroop Color and Word test\
. Rey Auditory Verbal Learning Test (RAVLT)\
. Wisconsin Card Sorting Test (64 item)WM, AV, VLM, RP, IP1Pen and paperNeuropsychologist\
Psychiatric nurse\
Graduate studentsYesAyres, 2010. Controlled Oral Word Association Test (COWAT)\
. Wechsler Adult Intelligence Scale (WAIS)VSM, AV, WMNRPen and paperNRNgoma, 2010. Rey 15 Item\
. Rey Complex Figure (RCF)\
. Letter number sequence task\
. Test of attention\
. Trail making test\
. Motor speed\
. Controlled Oral Word Association Test (COWAT)\
. Stroop Color and Word test\
. Wisconsin Card Sorting Test (256 version)\
. Trail making testVLM, VSM, WM, AV, MS, RPNRPen and paperClinical psychologistNRCabral-Calderin, 2010. Emotional Expression Multimorph tasksocial CognitionNRNRNRNRMehta, 2011. Social cognition rating scale in Indian SettingsSocial cognitionNRNRNRNRGuo, 2011. Wechsler Adult Intelligence Scale (WAIS) (Revised)\
. Wisconsin card sorting test\
. Wechsler Adult Intelligence Scale (WAIS) (Revised)\
. Wechsler Memory Scale (Revised)IP, RP, WM, VSMNRPen and paperNeuropsychologistNRNakasujja, 2012. WHO UCLA Auditory verbal learning test\
. Symbol digit modalities test\
. Verbal fluency\
. Wechsler Adult Intelligence Scale version III (WAIS)VLM, AV, WM, RP, IPNRPen and paperNRNRSantosh, 2013. Trail making test part B\
. Trail making test part A\
. Stroop test\
. Digit span\
. Verbal fluency testRP, IP, AV, WM, VLMNRNRNRNRHeeramun-Aubeeluck, 2014. Paced Auditory Serial\
. Wechsler Memory Scale\
. Wechsler Adult Intelligence Scale (WAIS)\
. Trail making\
. Hopkins Verbal Learning Test (Revised)\
. Brief Visuospatial Memory Test (Revised)WM, IP, VLM, VSMNRNRNRYesOkasha, 2014. Weschler memory scale\
. Continuous performance tests\
. Wisconsin Card Sorting testWM, VSM, VLM, AV, RP,3.5pen and paperResearch assistantsNRMazhari, 2014. 15 item word list\
. Digit sequencing task\
. Token motor task\
. COWAT\
. Symbol coding\
. Tower of London\
. Trail making BVLM, WM, AV. RP, IP0.67Pen and paperNRNRArau´ jo, 2015. Rey Auditory-Verbal Learning Test\
. Wechsler Adult Intelligence Scale (WAIS) (Version III)\
. Trail Making test\
. Controlled Oral Word Association Test (COWAT)\
. Wisconsin Card Sort Test (128 cards)VLM, WM, IP, VSM, AV, RP0.68Pen and paperNRNRHou, 2016. Trail making\
. Stroop color word test\
. Hopkins Verbal Learning Test-Revised (HVLT-R)IP, AV, VLMNRNRNRNRTang, 2016. Facial emotional recognition taskSCNRNRNRNRCharernboon, 2017. Emotion perception\
. Theory of mind\
. Social knowledgeSCNRNRNRNRZhou, 2017. Hopkins Verbal Learning Test-revised\
. The Verbal Fluency Test, Chinese version\
. The Color Trails Test\
. Stroop Color Word Test Chinese version\
. Cambridge PM Test (C-CAMPROMPT)WM, VLM, AV, RPNRComputerNRNRHendricks, 2017. Controlled Oral Word Association Test (COWAT)\
. Trail Making Test\
. Rey Auditory Verbal Learning Test (RAVLT)\
. Visual Reproduction Trails\
. Rey Complex Figure (RCF)\
. Rey 15 Item\
. Wechsler Adult Intelligence Scale (WAIS) (South African)\
. clock drawing testVLM, AV, IP, WM, VSM, RPNRPen and paperNeuropsychologistNRSagar, 2018. Post graduate institute memory scale\
. National Institute of Mental Health and Neuro-Sciences neuropsychology battery\
. Verbal working memoryAV, WM,RP, VLM1Pen and PaperNeuropsychologistNR[^3]

3.5. Setting where tests were performed {#s0060}
---------------------------------------

[Table 1](#t0005){ref-type="table"} highlights the clinic setting in which the tests were performed. Twenty-four studies were conducted in an outpatient population, 5 were carried out among inpatients and 2 in both outpatient and inpatient populations.

3.6. Administration of tests with support of technology {#s0065}
-------------------------------------------------------

Four studies ([@bb0120]; [@bb0225]; [@bb0295]; [@bb0290]) used nonspecialised health professionals to perform the tests. Most tests were performed by a neuropsychologist; or by trained research assistant/graduate trainee. Four out of 31 studies used computerized assessments. This is highlighted in [Table 3](#t0015){ref-type="table"}.

3.7. Follow up of participants {#s0070}
------------------------------

Only one study ([@bb0005]) reported on the quality of life of the participants. Only 6/31 studies (19.4%) utilised a longitudinal study design. These longitudinal studies are highlighted in [Table 1](#t0005){ref-type="table"}.

4. Risk of bias across studies {#s0075}
==============================

There was extensive publication bias (p ≤ 0.005) as shown in the funnel plot ([Fig. 4](#f0020){ref-type="fig"}). Published studies (circles) and unpublished studies (squares) in the funnel plot were estimated from the trim-and-fill method. The solid line corresponds to adjustments for the impact of publication bias summary effect and the dashed line to the unadjusted summary effect.Fig. 4Filled funnel plot with pseudo 95% confidence limits showing publication bias.Fig. 4

5. Discussion {#s0080}
=============

The research done to date suggests several gaps in the field. Only three studies performed neuropsychological assessments in patients with a first episode of psychosis ([@bb0125]; [@bb0135]; [@bb0325]). It is recommended that assessments are performed at the earliest opportunity ([@bb0010]; [@bb0320]; [@bb0240]; [@bb0150]). There is need to validate tools for use among patients with a first episode of psychosis in [LMIC](#dt0005){ref-type="term"}s ([@bb0090]; [@bb0190]).

The number of studies in which tests were validated against a comprehensive neuropsychological battery was low ([@bb0180]; [@bb0175]; [@bb0020]). More studies in which the performance of brief tests is compared against comprehensive batteries like the MATRICS consensus cognitive battery (MCCB) are needed. To date most studies have compared the performance of comprehensive batteries like the CogState and the MOCA which have little utility in LMICs with MCCB ([@bb0085]; [@bb0160]). However, the results of these studies provide some support for validity.

In 6 out of 31 studies ([@bb0285]; [@bb0290]; [@bb0295]; [@bb0175]; [@bb0020]; [@bb0280]), the assessment took \<1 h to assess for impairment in five domains, which is attractive for clinical application. Most tests assessed for impairment in the reasoning and problem-solving domain ([@bb0110]; [@bb0170]; [@bb0070]; [@bb0120]; [@bb0005]; [@bb0030]; [@bb0285]; [@bb0310]; [@bb0235]; [@bb0290]; [@bb0295]; [@bb0210]; [@bb0105]; [@bb0200]; [@bb0175]; [@bb0020]; [@bb0130]; [@bb0325]; [@bb0280]). This seems clinically useful given literature from high-income countries that the greatest burden of cognitive impairment is in the cognitive domains of attention/vigilance, memory and reasoning and problem-solving among chronic patients ([@bb0275]).

In this review, only three studies used nonspecialised staff to perform the neuropsychological assessments ([@bb0120]; [@bb0290]; [@bb0295]). This raises concern about the clinical utility of these measures in LMICs, where there are few specialized staff ([@bb0075]; [@bb0195]; [@bb0300]). [mHealth](#dt0015){ref-type="term"} apps may be more cost-efficient and feasible for delivery by non-specialized staff ([@bb0145]; [@bb0215]; [@bb0255]). Evidence suggests that tests delivered via mHealth applications are more efficient, accurate, accessible and interactive than assessments delivered via pen and paper ([@bb0035]).

Most tests were performed using pen and paper tests ([@bb0110]; [@bb0170]; [@bb0070]; [@bb0120]; [@bb0005]; [@bb0030]; [@bb0285]; [@bb0235]; [@bb0290]; [@bb0295]; [@bb0060]; [@bb0210]; [@bb0105]; [@bb0200]; [@bb0175]; [@bb0225]; [@bb0020]; [@bb0130]; [@bb0280]). Limitations of paper based assessments include human error in data collection, the additional time required to score the assessments after they have been administered, costs associated with obtaining copyrighted and proprietary forms, and the burden of transporting and storing hard-copy questionnaires ([@bb0245]). Further work is warranted on the use of electronic assessments using mobile technology (mHealth applications, or "[apps](#dt0010){ref-type="term"}") as is already being done in other populations such as persons living with HIV/AIDS ([@bb0045]; [@bb0250]; [@bb0255]).

Few studies were of a longitudinal study design, and so it is unclear whether these tests are useful for monitoring progress and outcomes ([@bb0050]; [@bb0105]; [@bb0200]; [@bb0125]; [@bb0325]; [@bb0280]). Also, only one study assessed for quality of life as an outcome ([@bb0005]) highlighting the strong associations between cognitive impairment and quality of life. There is need for further studies on the ability of tests to be used in longitudinal studies.

One limitation of our own work deserves emphasis: we searched for English publications only and so may have missed studies published in other languages. Also, the WGSA criteria are not entirely specific on what characteristics constitute the threshold for meeting a criterion. We welcome scrutiny of our study descriptions into what may constitute meeting the WGSA criteria. A further limitation is that our criteria were based on findings from research on these measures, whereas the criteria are intended to address clinical use of these measures.

In conclusion, measures that have been used in research on psychotic disorders in low- and middle-income countries meet only some WCGA clinical utility criteria. Several candidate assessments are, however, attractive in terms of their scope and duration, and at least one of these, the Brief Assessment of Cognition in Schizophrenia; has been validated in high-income settings ([@bb0055]; [@bb0155]; [@bb0285]; [@bb0175]; [@bb0020]). Further work on the administration of measures performed by non-specialized staff using mHealth apps is recommended in low and middle-income contexts.

List of abbreviations {#s0085}
=====================

[LMIC](#p0110){ref-type="p"}low- and middle-income country[Apps](#p0130){ref-type="p"}application[mHealth](#p0125){ref-type="p"}mobile health
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[^1]: FES=first episode schizophrenia, HC = healthy controls, BPD = bipolar affective disorder, FEP = first episode psychosis, NOS = not otherwise specified.

[^2]: BACS - Brief Assessment of Cognition in Schizophrenia; MOCA - Montreal Cognitive Assessment.

[^3]: WM = working memory, AV = attention/vigilance, VLM = verbal learning and memory, VSM = visual learning and memory, RP = reasoning and problem solving, IP = information processing speed, and SC = social cognition. NR = Not reported.
